Other Information	6 Months Ended
Jun. 30, 2011
Other Information
Other Information	PART II – OTHER INFORMATION ITEM 1. LEGAL PROCEEDINGS The Company has three wage claims made by former employees. Denise Cox $27,017.16, Diane Cox $30,250.54 and Don Cox $216,335.65. Diane Cox and Denise Cox have filed suit and the Company has disputed the claims and retained counsel to defend. The Company also disputes the claim of Don Cox and intends to defend any action that might be brought. In February a note holder brought suit for payment of a $60,000 note due plus interest. The Company is negotiating a settlement. A former Director Bill Sparks has brought suit for payment for two notes due April 1, 2010. The first is $14,000 and the second is $50,000 plus interest. The company is negotiation a settlement. ITEM 1A. RISK FACTORS There have been no material changes from the risk factors disclosed in Item 1A to Part I of our annual report on Form 10-K for the year ended December 31, 2010. ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 1. In January 2011, the Company granted 100,000 to a consultant as full compensation for the consultant’s services. There were no proceeds from the share issuance, and no fees were paid in connection with the transaction. 2. In February 2011, the Company issued an aggregate of $20,000 in convertible notes to a director and two other investors. The notes accrue interest at the rate of 8% per annum and are due and payable in February 2012. The notes are convertible, at the option of the noteholder, into shares of common stock at a conversion price equal to 80% of the ten day VWAP of the Company’s common stock measured from the conversion date. 3. In March 2011, the Company entered into a Securities Purchase Agreement with one investors providing for the issuance of the 8% Convertible Promissory Note in the principal amount of $65,000. The Note matures in March 2012. The Note is unsecured. Under the terms of the conversion rights, the noteholder has the right during the term of the note to convert all or part of the outstanding and unpaid principal amount of the note into common stock at conversion price that is equal to a 45% discount rate of the market price. The market price is defined as the average of the lowest three (3) trading prices for the common stock during a ten (10) day trading period ending on the latest complete trading prior to the conversion date. 4. In June 2011, the Company issued two convertible promissory notes in the aggregate principal amount of $16,000. The notes mature June 1, 2012. The notes are convertible into shares of common stock at a conversion price of $.06 per share. 5. In June 2011, the Company issued five convertible notes in the aggregate principal amount of $108,100. The notes were sold to related parties and shareholders. The notes accrue interest at the rate of 8% per annum and are due and payable June 1, 2012. The notes are convertible into shares of common stock at a conversion price of $.06 per share. 6. In the second quarter of 2011, the Company entered into a Separation Agreement and Release with a former officer and director. Under the terms of the Agreement, the Company issued 550,000 in payment of accrued compensation. The Company also granted warrants exercisable to purchase an additional 200,000 shares at an exercise price of $.10 per share. The Warrants expire June 20, 2014. 7. In June 2011, the Company agreed to issue 200,000 shares of common stock to its legal counsel in partial payment of accrued fees. Concurrently, the Company granted a put option pursuant to which the shares can be put back to the Company beginning in November 2011 requiring the Company to redeem the shares for cash payment of $.0875 per share. All cash proceeds received by the Company in connection with the foregoing transactions was used for working capital. No fees or commissions were paid. In each of the foregoing, the securities were issued without registration under the Securities Act of 1933, as amended, in reliance upon an exemption from the registration requirements of the Securities Act set forth in Section 4(2) thereof. The securities in each instance were taken for investment purposes, were restricted as to resale, and the instruments evidencing same contained the Company’s customary restrictive legend. Each of the investors was either an accredited investor within the meaning of Rule 501(a) under the Securities Act or provided an attestation with respect to their financial sophistication. ITEM 3. DEFAULTS UPON SENIOR SECURITIES None, except as previously disclosed.. ITEM 4. REMOVED AND RESERVED ITEM 5. OTHER INFORMATION None.

Other Information

6 Months Ended

Jun. 30, 2011

PART II – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

The Company has three wage claims made by former employees. Denise Cox $27,017.16, Diane Cox $30,250.54 and Don Cox $216,335.65. Diane Cox and Denise Cox have filed suit and the Company has disputed the claims and retained counsel to defend. The Company also disputes the claim of Don Cox and intends to defend any action that might be brought.

In February a note holder brought suit for payment of a $60,000 note due plus interest. The Company is negotiating a settlement.

A former Director Bill Sparks has brought suit for payment for two notes due April 1, 2010. The first is $14,000 and the second is $50,000 plus interest. The company is negotiation a settlement.

ITEM 1A. RISK FACTORS

There have been no material changes from the risk factors disclosed in Item 1A to Part I of our annual report on Form 10-K for the year ended December 31, 2010.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

1. In January 2011, the Company granted 100,000 to a consultant as full compensation for the consultant’s services. There were no proceeds from the share issuance, and no fees were paid in connection with the transaction.

2. In February 2011, the Company issued an aggregate of $20,000 in convertible notes to a director and two other investors. The notes accrue interest at the rate of 8% per annum and are due and payable in February 2012. The notes are convertible, at the option of the noteholder, into shares of common stock at a conversion price equal to 80% of the ten day VWAP of the Company’s common stock measured from the conversion date.

3. In March 2011, the Company entered into a Securities Purchase Agreement with one investors providing for the issuance of the 8% Convertible Promissory Note in the principal amount of $65,000. The Note matures in March 2012. The Note is unsecured. Under the terms of the conversion rights, the noteholder has the right during the term of the note to convert all or part of the outstanding and unpaid principal amount of the note into common stock at conversion price that is equal to a 45% discount rate of the market price. The market price is defined as the average of the lowest three (3) trading prices for the common stock during a ten (10) day trading period ending on the latest complete trading prior to the conversion date.

4. In June 2011, the Company issued two convertible promissory notes in the aggregate principal amount of $16,000. The notes mature June 1, 2012. The notes are convertible into shares of common stock at a conversion price of $.06 per share.

5. In June 2011, the Company issued five convertible notes in the aggregate principal amount of $108,100. The notes were sold to related parties and shareholders. The notes accrue interest at the rate of 8% per annum and are due and payable June 1, 2012. The notes are convertible into shares of common stock at a conversion price of $.06 per share.

6. In the second quarter of 2011, the Company entered into a Separation Agreement and Release with a former officer and director. Under the terms of the Agreement, the Company issued 550,000 in payment of accrued compensation. The Company also granted warrants exercisable to purchase an additional 200,000 shares at an exercise price of $.10 per share. The Warrants expire June 20, 2014.

7. In June 2011, the Company agreed to issue 200,000 shares of common stock to its legal counsel in partial payment of accrued fees. Concurrently, the Company granted a put option pursuant to which the shares can be put back to the Company beginning in November 2011 requiring the Company to redeem the shares for cash payment of $.0875 per share.

All cash proceeds received by the Company in connection with the foregoing transactions was used for working capital. No fees or commissions were paid. In each of the foregoing, the securities were issued without registration under the Securities Act of 1933, as amended, in reliance upon an exemption from the registration requirements of the Securities Act set forth in Section 4(2) thereof. The securities in each instance were taken for investment purposes, were restricted as to resale, and the instruments evidencing same contained the Company’s customary restrictive legend. Each of the investors was either an accredited investor within the meaning of Rule 501(a) under the Securities Act or provided an attestation with respect to their financial sophistication.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None, except as previously disclosed..

ITEM 4. REMOVED AND RESERVED

ITEM 5. OTHER INFORMATION

None.

BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC 10-Q/A